{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:34:54Z","timestamp":1751481294178},"reference-count":31,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1034,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/dth.12010","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T16:53:31Z","timestamp":1355417611000},"page":"S10-S16","source":"Crossref","is-referenced-by-count":20,"special_numbering":"supplement S1","title":["Classification of vitiligo: a challenging endeavor"],"prefix":"10.1155","volume":"25","author":[{"given":"Jana","family":"Hercogov\u00e1","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology; 2nd Medical School; Charles University of Prague; Prague; Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Dermatology and Pathology; New Jersey Medical School; Newark; New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torello M.","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"key":"10.1111\/dth.12010-BIB0001|dth12010-cit-0001","first-page":"18","volume-title":"Vitiligo - problems and solutions","year":"2004"},{"key":"10.1111\/dth.12010-BIB0002|dth12010-cit-0002","first-page":"546","article-title":"Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes","volume":"44","author":"Shajil","year":"2006","journal-title":"Indian J Exp Biol"},{"key":"10.1111\/dth.12010-BIB0003|dth12010-cit-0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archderm.1982.01650130009007","article-title":"Vitiligo. It is important","volume":"118","author":"Nordlund","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1111\/dth.12010-BIB0004|dth12010-cit-0004","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1046\/j.1365-4362.2003.01908.x","article-title":"Vitiligo in the Nigerian African: a study on 351 patients in Benin City in Nigeria","volume":"42","author":"Onunu","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1111\/dth.12010-BIB0005|dth12010-cit-0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","article-title":"Segmental vitiligo: clinical findings in 208 patients","volume":"35","author":"Hann","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12010-BIB0006|dth12010-cit-0006","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0190-9622(95)91282-7","article-title":"An epidemiologic case-control study in a population with vitiligo","volume":"33","author":"Barona","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12010-BIB0007|dth12010-cit-0007","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1111\/dth.12010-BIB0008|dth12010-cit-0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/9780470760116.ch4","volume-title":"Vitiligo: a monograph on the basic and clinical science","author":"Majumder","year":"2000"},{"key":"10.1111\/dth.12010-BIB0009|dth12010-cit-0009","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-4632.2006.02907.x","article-title":"Genetic epidemiology of vitiligo: a study of 815 probands and their families from South China","volume":"45","author":"Sun","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/dth.12010-BIB0010|dth12010-cit-0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000131501","article-title":"The genetics of generalized vitiligo","volume":"10","author":"Spritz","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"10.1111\/dth.12010-BIB0011|dth12010-cit-0011","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1755-148X.2009.00543.x","article-title":"CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data","volume":"22","author":"Birlea","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/dth.12010-BIB0012|dth12010-cit-0012","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/dth.12010-BIB0013|dth12010-cit-0013","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1086\/375451","article-title":"A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci","volume":"72","author":"Fain","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1111\/dth.12010-BIB0014|dth12010-cit-0014","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel vitiligo susceptibility loci on chromosome 7 (AIS2) and 8 (AIS3) confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis","volume":"74","author":"Spritz","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1111\/dth.12010-BIB0015|dth12010-cit-0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","volume":"7","author":"Bystryn","year":"1989","journal-title":"Clin Dermatol"},{"key":"10.1111\/dth.12010-BIB0016|dth12010-cit-0016","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12476636","article-title":"Cytolytic antibodies to melanocytes in vitiligo","volume":"100","author":"Cu","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12010-BIB0017|dth12010-cit-0017","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/dth.12010-BIB0018|dth12010-cit-0018","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2133.1994.tb08486.x","article-title":"Neuropeptide and neuronal marker studies in vitiligo","volume":"131","author":"Al'Abadie","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12010-BIB0019|dth12010-cit-0019","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0749.1992.tb00003.x","article-title":"Catecholamines and vitiligo","volume":"5","author":"Morrone","year":"1992","journal-title":"Pigment Cell Res"},{"key":"10.1111\/dth.12010-BIB0020|dth12010-cit-0020","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.8128228","article-title":"Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin","volume":"263","author":"Schallreuter","year":"1994","journal-title":"Science"},{"key":"10.1111\/dth.12010-BIB0021|dth12010-cit-0021","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/bbrc.1994.2423","article-title":"Cytotoxicity of 6-biopterin to human melanocytes","volume":"204","author":"Schallreuter","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/dth.12010-BIB0022|dth12010-cit-0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/dth.12010-BIB0023|dth12010-cit-0023","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0925-4439(94)90027-2","article-title":"Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo","volume":"1226","author":"Schallreuter","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/dth.12010-BIB0024|dth12010-cit-0024","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2133.1999.02980.x","article-title":"Serum selenium levels and blood glutathione peroxidase activities in vitiligo","volume":"141","author":"Beazley","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12010-BIB0025|dth12010-cit-0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1111\/dth.12010-BIB0026|dth12010-cit-0026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","article-title":"Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo","volume":"148","author":"Gauthier","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12010-BIB0027|dth12010-cit-0027","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2133.1997.18011894.x","article-title":"Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocytes adhesion","volume":"137","author":"Le Poole","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12010-BIB0028|dth12010-cit-0028","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/path.1538","article-title":"Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF\/KIT protein interaction and the downstream effector, MITF-M","volume":"202","author":"Kitamura","year":"2004","journal-title":"J Pathol"},{"key":"10.1111\/dth.12010-BIB0029|dth12010-cit-0029","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12010-BIB0030|dth12010-cit-0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0190-9622(00)90170-1","article-title":"Clinical and histopathologic characteristics of trichrome vitiligo","volume":"42","author":"Hann","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12010-BIB0031|dth12010-cit-0031","first-page":"928","volume-title":"Dermatology","author":"Ortonne","year":"2008"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12010","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12010\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:59:40Z","timestamp":1671818380000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12010"}},"subtitle":["Vitiligo classification"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1111\/dth.12010","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}